142 related articles for article (PubMed ID: 21473129)
1. [Lacosamide--oral administration (Vimpat) ].
Duh D; Peeters S
J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
[No Abstract] [Full Text] [Related]
2. [Lacosamide in the treatment of epilepsy].
Petrukhin AS; Voronkova KV; Pylaeva OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):65-71. PubMed ID: 22983249
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
4. Lacosamide for epilepsy.
Med Lett Drugs Ther; 2009 Jun; 51(1315):50-2. PubMed ID: 19556941
[No Abstract] [Full Text] [Related]
5. Lacosamide: new drug. Refractory partial epilepsy: optimise existing combinations.
Prescrire Int; 2009 Oct; 18(103):196. PubMed ID: 19882781
[No Abstract] [Full Text] [Related]
6. New epilepsy treatment receives FDA approval.
Lavine G
Am J Health Syst Pharm; 2008 Dec; 65(24):2310. PubMed ID: 19052267
[No Abstract] [Full Text] [Related]
7. [Antiepileptic drug lacosamide(vimpat)].
Zenkov LR
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):72-9. PubMed ID: 21510453
[No Abstract] [Full Text] [Related]
8. Lacosamide and epilepsy.
Harris JA; Murphy JA
CNS Neurosci Ther; 2011 Dec; 17(6):678-82. PubMed ID: 20950330
[TBL] [Abstract][Full Text] [Related]
9. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
10. The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents.
Higgins GA; Breysse N; Undzys E; Kuo C; Joharchi N; Derksen DR; Xin T; Isaac M; Slassi M
Eur J Pharmacol; 2009 Dec; 624(1-3):1-9. PubMed ID: 19818346
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide-induced rash.
Koubeissi MZ; Vismer M; Ehrlich A
Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide intoxication in attempted suicide.
Bauer S; David Rudd G; Mylius V; Hamer HM; Rosenow F
Epilepsy Behav; 2010 Apr; 17(4):549-51. PubMed ID: 20171144
[TBL] [Abstract][Full Text] [Related]
13. [Lacosamide (vimpat). Prospects for clinical application].
Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
[TBL] [Abstract][Full Text] [Related]
15. What is the right dose of lacosamide in pediatric patients with intractable epilepsy?
Vishwanath VA; Miller LM
Epilepsy Behav; 2012 Mar; 23(3):396-7. PubMed ID: 22381391
[No Abstract] [Full Text] [Related]
16. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
Novy J; Patsalos PN; Sander JW; Sisodiya SM
Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide use in refractory idiopathic primary generalized epilepsy.
Zangaladze A; Skidmore C
Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic drug monitoring of lacosamide].
Bentué-Ferrer D; Tribut O; Verdier MC
Therapie; 2012; 67(2):151-5. PubMed ID: 22850102
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide.
Perucca E; Yasothan U; Clincke G; Kirkpatrick P
Nat Rev Drug Discov; 2008 Dec; 7(12):973-4. PubMed ID: 19043448
[TBL] [Abstract][Full Text] [Related]
20. New drugs: Febuxostat, lacosamide, and rufinamide.
Hussar DA; Bilbow C
J Am Pharm Assoc (2003); 2009; 49(3):460-3. PubMed ID: 19443330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
